Advertisement
Loading...

Immutep Limited

PRRUF•PNK
Healthcare
Biotechnology
$0.05
$0.00(0.00%)
U.S. Market is Open • 15:41

Immutep Limited (PRRUF) Stock Overview

Explore Immutep Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap73.7M
P/E Ratio-1.61
EPS (TTM)$-0.04
ROE-0.53%
Fundamental Analysis

AI Price Forecasts

1 Month$0.06
3 Months$0.20
1 Year Target$0.24

PRRUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immutep Limited (PRRUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.61 and a market capitalization of 73.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-23.08%
3-Month Change
-80.00%
6-Month Change
-72.22%
Year-to-Date (YTD) Change
-84.38%
1-Year Change
-77.27%
3-Year Change
-79.17%
5-Year Change
-87.50%
All-Time (Max) Change
1566.67%

Contact Information

https://www.immutep.com
61 2 8315 7003
Australia Square, Sydney, NSW, 2000

Company Facts

51 Employees
IPO DateFeb 22, 2012
CountryAU
Actively Trading

Frequently Asked Questions